About David Weinmann
Form D filings for Biopharmaceutical Research in 2023 list David Weinmann as executive officer.
David Weinmann first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David Weinmann in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Weinmann works with at each company, as listed on that company's latest Form D.
Biopharmaceutical Research Co · Form D, Aug 9, 2023
CS
Charles Schumacher
Director
GH
George Hodgin
Chief Executive Officer and director
OI
Osagie Imasogie
Director